摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-formyl-1,10-phenanthroline 2,6-dichloroanil | 876126-89-5

中文名称
——
中文别名
——
英文名称
2-formyl-1,10-phenanthroline 2,6-dichloroanil
英文别名
N-(2,6-dichlorophenyl)-1-(1,10-phenanthrolin-2-yl)methanimine
2-formyl-1,10-phenanthroline 2,6-dichloroanil化学式
CAS
876126-89-5
化学式
C19H11Cl2N3
mdl
——
分子量
352.222
InChiKey
OOAHRQKSHIYJPI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    116-118 °C
  • 沸点:
    593.4±50.0 °C(Predicted)
  • 密度:
    1.36±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5.3
  • 重原子数:
    24
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    38.1
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    iron(II) chloride tetrahydrate 、 2-formyl-1,10-phenanthroline 2,6-dichloroanil四氢呋喃 为溶剂, 以56%的产率得到[(2-formyl-1,10-phenanthroline 2,6-dichloroanil)]FeCl2
    参考文献:
    名称:
    带有2-Imino-1,10-菲咯啉基配体的铁络合物作为乙烯低聚反应的高活性催化剂
    摘要:
    合成了一系列由2-亚氨基-1,10-菲咯啉基配体LFeCl 2(L = 2-(ArN CR)-1,10-phen)连接的铁配合物,并通过元素和光谱分析以及X进行了充分表征射线衍射分析。这些铁(II)配合物被甲基铝氧烷(MAO)或改性甲基铝氧烷(MMAO)活化,显示出高达8.95×10 7 g mol - 1(Fe)h - 1的高催化活性。用于乙烯低聚。产生的低聚物的分布遵循对α-烯烃具有高选择性的Schluz-Flory规则。配位体的空间和电子效应都影响催化活性和催化产物的性质。还研究了反应条件的参数以探索这些配合物的催化潜力。
    DOI:
    10.1021/om050891p
点击查看最新优质反应信息

文献信息

  • Ethylene oligomerization processes
    申请人:Chevron Phillips Chemical Company LP
    公开号:US10407360B2
    公开(公告)日:2019-09-10
    Disclosed herein is a process for forming an oligomer product comprising (a) introducing into a reaction zone (i) ethylene; (ii) a heteroatomic ligand metal salt complex comprising a heteroatomic ligand complexed to a first metal salt; (iii) a second metal salt wherein an equivalent molar ratio of the second metal salt to the heteroatomic ligand of the heteroatomic ligand metal salt complex is at least 0.5:1 and where the second metal salt is an iron salt, a cobalt salt, or any combination thereof; (iv) an organoaluminum compound; and (b) forming an oligomer product. Also disclosed herein is a process comprising (a) introducing into a reaction zone (i) ethylene; (ii) a heteroatomic ligand; (iii) a metal salt where an equivalent molar ratio of the metal salt to the heteroatomic ligand is at least 1.5:1; (iv) an organoaluminum compound; and (b) forming an oligomer product.
    本文公开了一种形成低聚物产品的工艺,包括(a)向反应区引入(i)乙烯;(ii)杂原子配体属盐络合物,包括与第一属盐络合的杂原子配体;(iii)第二属盐,其中第二属盐与杂原子配体属盐络合物的杂原子配体的等效摩尔比至少为0.5:1,其中第二属盐为盐、盐或其任意组合;(iv)有机铝化合物;以及(b)形成低聚物产物。本文还公开了一种工艺,包括(a)向反应区引入(i)乙烯;(ii)杂原子配体;(iii)属盐,其中属盐与杂原子配体的当量摩尔比至少为 1.5:1;(iv)有机铝化合物;以及(b)形成低聚物产物。
  • Ethylene oligomerization process
    申请人:Chevron Phillips Chemical Company LP
    公开号:US10544070B2
    公开(公告)日:2020-01-28
    Disclosed herein is a process for forming an oligomer product comprising (a) introducing into a reaction zone (i) ethylene; (ii) a heteroatomic ligand metal salt complex comprising a heteroatomic ligand complexed to a first metal salt; (iii) a second metal salt wherein an equivalent molar ratio of the second metal salt to the heteroatomic ligand of the heteroatomic ligand metal salt complex is at least 0.5:1 and where the second metal salt is an iron salt, a cobalt salt, or any combination thereof; (iv) an organoaluminum compound; and (b) forming an oligomer product. Also disclosed herein is a process comprising (a) introducing into a reaction zone (i) ethylene; (ii) a heteroatomic ligand; (iii) a metal salt where an equivalent molar ratio of the metal salt to the heteroatomic ligand is at least 1.5:1; (iv) an organoaluminum compound; and (b) forming an oligomer product.
    本文公开了一种形成低聚物产品的工艺,包括(a)向反应区引入(i)乙烯;(ii)杂原子配体属盐络合物,包括与第一属盐络合的杂原子配体;(iii)第二属盐,其中第二属盐与杂原子配体属盐络合物的杂原子配体的等效摩尔比至少为0.5:1,其中第二属盐为盐、盐或其任意组合;(iv)有机铝化合物;以及(b)形成低聚物产物。本文还公开了一种工艺,包括(a)向反应区引入(i)乙烯;(ii)杂原子配体;(iii)属盐,其中属盐与杂原子配体的当量摩尔比至少为 1.5:1;(iv)有机铝化合物;以及(b)形成低聚物产物。
  • ETHYLENE OLIGOMERIZATION PROCESSES
    申请人:Chevron Phillips Chemical Company LP
    公开号:EP3562799A1
    公开(公告)日:2019-11-06
  • Ethylene Oligomerization Processes
    申请人:Chevron Phillips Chemical Company LP
    公开号:US20190194089A1
    公开(公告)日:2019-06-27
    Disclosed herein is a process for forming an oligomer product comprising (a) introducing into a reaction zone (i) ethylene; (ii) a heteroatomic ligand metal salt complex comprising a heteroatomic ligand complexed to a first metal salt; (iii) a second metal salt wherein an equivalent molar ratio of the second metal salt to the heteroatomic ligand of the heteroatomic ligand metal salt complex is at least 0.5:1 and where the second metal salt is an iron salt, a cobalt salt, or any combination thereof; (iv) an organoaluminum compound; and (b) forming an oligomer product. Also disclosed herein is a process comprising (a) introducing into a reaction zone (i) ethylene; (ii) a heteroatomic ligand; (iii) a metal salt where an equivalent molar ratio of the metal salt to the heteroatomic ligand is at least 1.5:1; (iv) an organoaluminum compound; and (b) forming an oligomer product.
  • [EN] ETHYLENE OLIGOMERIZATION PROCESSES<br/>[FR] PROCÉDÉS D'OLIGOMÉRISATION D'ÉTHYLÈNE
    申请人:CHEVRON PHILLIPS CHEMICAL CO LP
    公开号:WO2018125826A1
    公开(公告)日:2018-07-05
    Disclosed herein is a process for forming an oligomer product comprising (a) introducing into a reaction zone (i) ethylene; (ii) a heteroatomic ligand metal salt complex comprising a heteroatomic ligand complexed to a first metal salt; (iii) a second metal salt wherein an equivalent molar ratio of the second metal salt to the heteroatomic ligand of the heteroatomic ligand metal salt complex is at least 0.5: 1 and where the second metal salt is an iron salt, a cobalt salt, or any combination thereof; (iv) an organoaluminum compound; and (b) forming an oligomer product. Also disclosed herein is a process comprising (a) introducing into a reaction zone (i) ethylene; (ii) heteroatomic ligand; (iii) a metal salt where an equivalent molar ratio of the metal salt to the heteroatomic ligand is at least 1.5: 1; (iv) an organoaluminum compound; and (b) forming an oligomer product.
查看更多

同类化合物

铁(2+)六氟磷酸盐-1,10-菲咯啉(1:2:3) 钼,四羰基(1,10-亚铁试剂(邻二氮杂菲)-kN1,kN10)-,(OC-6-22)- 钌(2+)高氯酸酯-1,10-亚铁试剂(邻二氮杂菲)(1:2:3) 邻菲罗啉 苯甲酸,4,4'-[2,8-二(1,1-二甲基乙基)-4,10-二氢芘[4,5-D:9,10-D']二咪唑-5,11-二酰基]双- 胶原脯氨酸羟化酶抑制剂-1 石杉碱乙 氯化-1,10-菲咯啉水合物 氯(甘氨酰酸基)(1,10-菲咯啉)铜(II) 新铜试剂 新亚铜灵盐酸 吡嗪并[2,3-f]的[1,10]菲咯啉 吡嗪并[2,3-f][1,10]菲罗啉-2,3-二甲腈 吡喃联氮基[1,2,3,4-lmn][1,10]菲并啉二正离子(8CI,9CI) 双(2-苯并[h]喹啉-C2,N')(乙酰丙酮)合铱(III) 双(2,2-二吡啶)-(5-氨基邻二氮杂菲)双(六氟磷酸)钌 双(1,10-菲罗啉)钯(II)双(六氟磷酸盐) 二苯基1,10-亚铁试剂(邻二氮杂菲)-4,7-二磺酸酯 二氯(1,10-菲咯啉)铜(II) 二氯(1,10-亚铁试剂)铂(II) 二氯(1,10-亚铁试剂)钯(II) 二吡啶并[3,2-a:2',3'-c]吩嗪 二(菲咯啉)(二吡啶并吩嗪)钌(II) 二(氰基)二(1,10-菲咯啉)-铁 二(1,10-菲咯啉)铜 三(1,10-菲咯啉)双(六氟磷酸盐)钴(II) 三(1,10-菲咯啉)三(六氟磷酸盐)钴(III) 三菲咯啉钴(III) 三氟甲基(1,10-菲咯啉)铜(I)[Trifluoromethylator®] 三-(1,10-菲咯啉)钌 三(苯甲酰丙酮酸根)单(邻二氮杂菲)铕(III) 三(二苯甲酰甲烷)单(5-氨基-1,10-菲罗啉)铕(III) 三(1,10-菲咯啉)硫酸铁 丁夫罗林 N-乙基-7,10-二氢-8-硝基-7-氧代-N-乙基-1,10-菲罗啉-3-甲酰胺 N-[4-(苯并[b][1,7]菲并啉-7-基氨基)-3-(甲基氨基)苯基]甲磺酰胺盐酸(1:1) B-1,10-菲罗啉-5-基硼酸 B-1,10-菲罗啉-2-基-硼酸 9-甲酰基-1,10-菲咯啉-2-羧酸 9-溴-1-甲基-1,10-菲咯啉-2-酮 9-氯-1-甲基-1,10-菲咯啉-2-酮 8,15-二去氢-17-甲基-石松定-1(18H)-酮 6-(2-碘苯基)亚氨基-1,10-菲咯啉-5-酮 6,7-二氢-5,8-二甲基二苯并(b,j)(1,10)菲咯啉 6,6'-二氰基-7,7'-二乙氧基-3,3'-(乙烷-1,2-二基)-5,5'-二苯基-2,2'-联-1,8-二氮杂萘 5-醛基-1,10-菲咯啉 5-羧基-1,10-菲罗啉 5-羟基-1,10-菲咯啉 5-硝基邻二氮杂菲-2,9-二羧酸一水合物 5-硝基-6氨基-1,10-邻菲罗啉